Tefron Ltd.
TFRFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 20.7% | 9.5% | -14.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 22.6% | 22.6% | 22.1% | 20.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.6% | 10.6% | 8.9% | 8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.1% | 4.5% | 3.3% | 5.5% |
| EPS Diluted | 1.13 | 0.86 | 0.55 | 1.15 |
| % Growth | 31.4% | 56.4% | -52.2% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |